Skip to main content

Research Repository

Advanced Search

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Forbes, John F; Sestak, Ivana; Howell, Anthony; Bonanni, Bernardo; Bundred, Nigel; Levy, Christelle; Minckwitz, Guntervon; Eiermann, Wolfgang; Neven, Patrick; Stierer, Michael; Holcombe, Chris; Coleman, Robert E; Jones, Louise; Ellis, Ian; Cuzick, Jack

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial Thumbnail


Authors

John F Forbes

Ivana Sestak

Anthony Howell

Bernardo Bonanni

Nigel Bundred

Christelle Levy

Guntervon Minckwitz

Wolfgang Eiermann

Patrick Neven

Michael Stierer

Chris Holcombe

Robert E Coleman

Louise Jones

Ian Ellis

Jack Cuzick



Journal Article Type Article
Acceptance Date Oct 11, 2015
Online Publication Date Dec 11, 2015
Publication Date Dec 22, 2015
Deposit Date Jan 24, 2018
Publicly Available Date Aug 3, 2020
Journal Lancet
Print ISSN 0140-6736
Electronic ISSN 1474-547X
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 387
Issue 10021
Pages 866-873
DOI https://doi.org/10.1016/S0140-6736%2815%2901129-0
Public URL https://nottingham-repository.worktribe.com/output/1118171
Publisher URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01129-0/fulltext
PMID 26686313

Files

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial (409 Kb)
PDF

Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/





Downloadable Citations